Detalhe da pesquisa
1.
Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy.
Drug Resist Updat
; 74: 101068, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402670
2.
Targeting CD24/Siglec-10 signal pathway for cancer immunotherapy: recent advances and future directions.
Cancer Immunol Immunother
; 73(2): 31, 2024 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279998
3.
Proximity-inducing modalities: the past, present, and future.
Chem Soc Rev
; 52(16): 5485-5515, 2023 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37477631
4.
Advances in the study of CD47-based bispecific antibody in cancer immunotherapy.
Immunology
; 167(1): 15-27, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35575882
5.
Crystal Structure of Human CD47 in Complex with Engineered SIRPα.D1(N80A).
Molecules
; 27(17)2022 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36080360
6.
Approaches to Evaluate the Impact of a Small-Molecule Binder to a Noncatalytic Site of the Proteasome.
Chembiochem
; 22(11): 1961-1965, 2021 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33617657
7.
Small-Molecule Inhibitors of the Proteasome's Regulatory Particle.
Chembiochem
; 20(14): 1739-1753, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30740849
8.
Effects of Autologous Platelet Rich Plasma on Intraoperative Transfusion and Short-Term Outcomes in Total Arch Replacement (Sun's Procedure): A Prospective, Randomized Trial.
J Cardiothorac Vasc Anesth
; 33(8): 2163-2169, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31060939
9.
Disrupting CD47-SIRPα axis alone or combined with autophagy depletion for the therapy of glioblastoma.
Carcinogenesis
; 39(5): 689-699, 2018 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29538621
10.
Inhibition of autophagy potentiated the anti-tumor effects of VEGF and CD47 bispecific therapy in glioblastoma.
Appl Microbiol Biotechnol
; 102(15): 6503-6513, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29754163
11.
A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity.
BMC Cancer
; 15: 170, 2015 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25881012
12.
OCILRP2 signaling synergizes with LPS to induce the maturation and differentiation of murine dendritic cells.
Biochem Biophys Res Commun
; 446(4): 836-42, 2014 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24631687
13.
Engineering approaches to manipulate osteoclast behavior for bone regeneration.
Mater Today Bio
; 26: 101043, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38600918
14.
Polymer Coating with Balanced Coordination Strength and Ion Conductivity for Dendrite-Free Zinc Anode.
Adv Mater
; 36(3): e2307727, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37820045
15.
IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy.
Antib Ther
; 6(4): 240-252, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37846296
16.
The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling.
Front Oncol
; 13: 1240061, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37849799
17.
A SIRPαFc Fusion Protein Conjugated With the Collagen-Binding Domain for Targeted Immunotherapy of Non-Small Cell Lung Cancer.
Front Immunol
; 13: 845217, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35422796
18.
SIRPα-Fc fusion protein IMM01 exhibits dual anti-tumor activities by targeting CD47/SIRPα signal pathway via blocking the "don't eat me" signal and activating the "eat me" signal.
J Hematol Oncol
; 15(1): 167, 2022 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36384978
19.
Targeting CD47 for cancer immunotherapy.
J Hematol Oncol
; 14(1): 180, 2021 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34717705
20.
Boosting Selective Nitrogen Reduction via Geometric Coordination Engineering on Single-Tungsten-Atom Catalysts.
Adv Mater
; 33(25): e2100429, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33998069